REQUEST A DEMO
Total
USD $0.00
Search more companies

Umedic Group Berhad (Malaysia)

Main Activities: Offices of Other Holding Companies
Full name: Umedic Group Berhad Profile Updated: November 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The Company was incorporated in Malaysia under the Act on 22 April 2021 as a private company limited by shares under the name of UMediC Group Sdn Bhd. On 28 September 2021, the company completed the Acquisitions which resulted in Actimed, Evo Medik, U Medihealth, UMediC, UWHC and UWHM becoming the wholly-owned subsidiaries. Subsequently, on 7 October 2021, the Company was converted to a public limited company to facilitate the Listing.
The Company's principal activity are marketing and distribution of various branded medical devices and consumables as well as the provision of after-sales services for all the products. The company also involved in developing, manufacturing and marketing for medical consumables.
Our history dates back to 8 November 2002 through the incorporation of UMediC (formerly known as UWC Healthcare Sdn Bhd) by Dato’ Ng Chai Eng (our Promoter and Non- Independent Non-Executive Chairman), Lau Chee Kheong (our Promoter and Non- Independent Non-Executive Director) and another business partner (who had ceased to be a director and shareholder in 2006) and was principally involved in the marketing and distribution of medical supplies and dental-related products and devices such as dental handpieces and local anaesthetic delivery systems. For this purpose, we set up two (2) marketing and distribution offices located in Bukit Minyak, Penang and Kuala Lumpur to serve the dental clinics within the northern and central regions of Peninsular Malaysia respectively.
In 2003, we diversified our marketing and distribution business to include medical devices for hospital settings in light of its growing potential and demand for such products. We distributed imported alternating pressure air mattresses and wheelchairs to both the public and private healthcare service providers within the Peninsular Malaysia. We mainly sourced the said medical devices from overseas suppliers in Taiwan and the UK. In the same year, we became an authorised distributor for Goldway (US) Inc (“Goldwayâ€) which allowed us to market and distribute Goldway branded patient monitors to our customers in the local healthcare industry.
In 2004, we extended our product offerings to include ambulance and paramedic equipment such as emergency stretchers, trauma kits, stand treatment trolleys as well as medical consumables namely wound care/management supplies. We did not secure any authorised distributorship for ambulance and paramedic equipment, medical devices and consumables. Hence, we sourced such items from local and overseas (i.e. Taiwan) suppliers
In 2005, we expanded our medical devices and consumables range to include bedside locker, overbed table, medical bed and medical suction apparatuses which offered to both the general ward, and accident and emergency departments.
In 2006, we ceased the marketing and distribution of dental-related products and devices and focused solely on the marketing and distribution of medical devices and consumables. This enabled us to concentrate on expanding our medical devices and consumables product offerings at a time when the industry was showing strong growth and good future prospects. In 2007, Evo Medik was incorporated to manage the marketing and distribution activities in the east coast region of Peninsular Malaysia.
In 2009, we set up a marketing and distribution office located in Kota Bharu, Kelantan and the office was subsequently consolidated into our office in the central region of Peninsular Malaysia in 2014. During the same year, we became an authorised distributor of Philips Goldway branded patient monitors and colposcopes after the acquisition of Goldway by Philips. Later in 2014, we were appointed as an authorised distributor of Philips Goldway branded cardiotocography monitors.
In 2010, we set up a marketing and distribution office located in Johor Bahru, Johor as we expanded to the southern region of Peninsular Malaysia through Actimed (which was incorporated in 2003 and subsequently changed its principal activity to the marketing and distribution of medical devices in 2009). Further, in the same year, we also expanded to Sarawak state through Actimed by sending our sales representatives to conduct marketing and promotional activities and also to work with local tendering agents, if required. During the same year, we were appointed as an authorised distributor by Philips to distribute its manual defibrillators for the hospital settings.
In 2012, we developed and commercialised our first HydroX series prefilled humidifiers. Within the same year, we further expanded our growing list of product offerings to include medical trolley and medical carts.
In 2013, UWHM’s QMS was assessed and accredited with ISO 9001:2008 and ISO 13485:2003 under the scope of “manufacture of prefilled humidifier content with sterile purified water†from BSI. These accreditations were subsequently updated to ISO 9001:2015, ISO 13485:2016 and EN ISO 13485:2016 in 2019, in compliance with “design and manufacture of prefilled humidifier and nebuliser content with sterile water for inhalation and respiratory gases, asthma inhaler space or holding chamber, humidity sensorâ€. We also received the Halal certification for our prefilled humidifiers from Majlis Agama Islam Pulau Pinang in 2013. In the same year, we successfully ventured into Thailand by supplying HydroX series prefilled humidifiers to the healthcare industry in the said country.
In 2014, we successfully marketed our HydroX series prefilled humidifiers to Indonesia and Philippines markets.
In 2015, UMediC and Evo Medik received GDPMD certification issued by BSI. UWHM was also granted a certificate of EC registration from BSI, under the scope of “the scope manufacture of sterile prefilled humidifier for respiratory gases (class IIa)â€, which certifies that our manufactured medical consumables comply with the European Commission health, safety and environment protection legislation, under the European Commission 93/42/EEC. In recognition of our outstanding contribution to the sales of Philips' medical products, we were awarded the Best Country Order Growth, Patient Care and Monitoring Solutions by Philips for year 2015. In the same year, we successfully ventured into Jordan and Saudi Arabia by supplying HydroX series prefilled humidifiers to the healthcare industry in the said countries.
In 2016, we were awarded the Best Channel Partner Performance, Value Segment for Patient Monitors by Philips during the year for extending the company’s sales reach for patient monitors. We established an in-house microbiology and chemical laboratory in order to improve our house brand R&D activities. During the year, we supplied our HydroX series prefilled humidifiers to India, Mauritius and Sri Lanka, to further expand our market coverage internationally.
In 2017, we entered into South Africa, Chile, Ecuador and South Korea by supplying HydroX series prefilled humidifiers to the healthcare industry in the said countries. In the same year, we commenced the development of sterile water for inhalation. As at the LPD, we have yet to commercialise sterile water for inhalation and expect to commercialise it in the first (1st) quarter of 2023.
In 2018, we secured authorised distributorship rights from E-Medtest (M) Sdn Bhd to distribute for a Denmark based anaesthesia machines manufacturer, Dameca branded general anaesthetic machines. In the same year, we also commenced the development of HydroX series prefilled nebulisers. As at the LPD, we have yet to commercialise HydroX series prefilled nebulisers and expect to commercialise it in the fourth (4th) quarter of 2023. We also ventured into Czech Republic, Myanmar, Pakistan, Kuwait, Moldova and Romania by supplying HydroX series prefilled humidifiers to these countries during the year. Also in 2018, UWHC1 was incorporated to commence new product development activities namely, AirdroX series inhaler spacers.
In 2019, we were appointed as an authorised distributor by Mindray and GE, which enabled us to distribute their ventilators and maternal and infant care products respectively. We were also appointed as an authorised distributor of Merit branded critical care consumables in the same year. During the same year, we began the construction of our new office and factor building that includes an ISO Class 7 cleanroom that enable us to undertake production activities which require restriction in the concentration of airborne particles permitted – on the Batu Kawan Land with a built up area of approximately 48,487.40 sq ft to better facilitate our business growth. UMediC’s QMS was assessed and accredited with ISO 13485:2016 under the scope of “manufacture of hospital stretchers, beds, carts and accessories†and “distribution, installation, testing and commissioning, maintenance, calibration of defibrillators, patient monitors and MRI patient monitoring system and accessories†from BSI. We further expanded our overseas market coverage by supplying HydroX series prefilled humidifiers to Croatia, Singapore and the United Arab Emirates in the same year.
In 2020, we secured authorised distributorship rights from Care Vision Healthcare Pte Ltd which allowed us to distribute SunLife Science branded electric-powered 3D chest compressors. In the same year, we received an appreciation award – Rising Star Award from Mindray. Our AirdroX series inhaler spacers have registered with the Belgian Federal Agency for Medicines and Health Products. We also won the Gold Award under Best Innovation Award category, Malaysia Technology Expo 2020 Special Edition – COVID-19 International Innovation Awards for our AirdroX series inhaler spacer and facemask (an anaesthetic facemask that connects to the inhaler spacer and is not intended to be sold separately). The recognition was given for the prototype of the AirdroX series inhaler spacers. In the same year, we successfully marketed our HydroX series prefilled humidifiers to other countries including Costa Rica, Italy, Japan, Kenya and Netherlands. Also in 2020, we commenced the development of digital oxygen flowmeters and humidifier humidity sensors.
In 2021, we relocated our operations to our new office and factory building on the Batu Kawan Land. We expanded our ventilator offerings to include Mindray’s neonatal ventilators in response to increasing demand due to the COVID 19 pandemic. In the same year, we expanded our overseas market coverage by supplying HydroX series prefilled humidifier to Bahrain and Brazil. We have completed the development of our AirdroX series inhaler spacers during the same year.
In June 2022, we have commercialised our AirdroX series inhaler spacers. We have yet to receive orders for AirdroX series inhaler spacers. However, we have been selling the prototype of AirdroX series inhaler spacers prior to its commercialisation.

Headquarters
Pmt 790, Jalan Cassia Selatan 5/2, Aman Perindustrian Batu Kawan, Bandar Cassia
Ayer Itam; Penang; Postal Code: 14110

Contact Details: Purchase the Umedic Group Berhad report to view the information.

Website: http://www.umedic.com.my

Basic Information
Outstanding Shares:
Purchase the Umedic Group Berhad report to view the information.
Financial Auditors:
Purchase the Umedic Group Berhad report to view the information.
Incorporation Date:
2021
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
5.46%
Purchase this report to view the information.
5.32%
Purchase this report to view the information.
4.75%
Subsidiaries
Actimed Healthcare Sdn.Bhd.
100%
Evo Medik Sdn. Bhd.
100%
U Medihealth Sdn Bhd
100%
Company Performance
Financial values in the chart are available after Umedic Group Berhad report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
20.11%
Total operating revenue
18.32%
Operating profit (EBIT)
-4.81%
EBITDA
-2.02%
Net Profit (Loss) for the Period
-10.32%
Total assets
12.79%
Total equity
14.64%
Operating Profit Margin (ROS)
-5.83%
Net Profit Margin
-5.78%
Return on Equity (ROE)
-3.56%
Debt to Equity Ratio
-4.53%
Quick Ratio
-2.53%
Cash Ratio
-0.92%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?